Suzhou Medsys Tech Co Ltd (603990) — Net Asset Quality Index
Suzhou Medsys Tech Co Ltd (603990) has a Net Asset Quality Index of 67.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.25 Billion minus total liabilities of CN¥404.57 Million yields net assets of CN¥843.80 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check 603990 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Suzhou Medsys Tech Co Ltd Net Asset Quality Index Over Time (2011–2024)
This chart shows how Suzhou Medsys Tech Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 67.6%, representing net assets of CN¥843.80 Million against total assets of CN¥1.25 Billion CNY. See Suzhou Medsys Tech Co Ltd (603990) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Suzhou Medsys Tech Co Ltd (2011–2024)
The table below presents the year-by-year Net Asset Quality Index for Suzhou Medsys Tech Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Suzhou Medsys Tech Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 25.4% | CN¥804.79 Million | CN¥3.16 Billion | CN¥2.36 Billion | ▼ -2.6 pp |
| 2023 | 28.1% | CN¥1.10 Billion | CN¥3.92 Billion | CN¥2.82 Billion | ▼ -55.3 pp |
| 2022 | 83.4% | CN¥1.36 Billion | CN¥1.63 Billion | CN¥270.78 Million | ▼ -0.2 pp |
| 2021 | 83.6% | CN¥1.10 Billion | CN¥1.31 Billion | CN¥215.86 Million | ▲ +2.0 pp |
| 2020 | 81.6% | CN¥1.24 Billion | CN¥1.52 Billion | CN¥280.22 Million | ▲ +14.9 pp |
| 2019 | 66.7% | CN¥507.18 Million | CN¥760.27 Million | CN¥253.08 Million | ▲ +0.7 pp |
| 2018 | 66.0% | CN¥473.16 Million | CN¥717.21 Million | CN¥244.06 Million | ▼ -3.3 pp |
| 2017 | 69.2% | CN¥433.79 Million | CN¥626.50 Million | CN¥192.72 Million | ▲ +12.0 pp |
| 2016 | 57.2% | CN¥394.97 Million | CN¥690.34 Million | CN¥295.37 Million | ▲ +14.3 pp |
| 2015 | 42.9% | CN¥186.63 Million | CN¥435.34 Million | CN¥248.70 Million | ▼ -10.1 pp |
| 2014 | 53.0% | CN¥147.68 Million | CN¥278.84 Million | CN¥131.16 Million | ▼ -2.6 pp |
| 2013 | 55.5% | CN¥108.43 Million | CN¥195.25 Million | CN¥86.82 Million | ▲ +0.8 pp |
| 2012 | 54.8% | CN¥77.35 Million | CN¥141.25 Million | CN¥63.90 Million | ▲ +32.7 pp |
| 2011 | 22.1% | CN¥18.91 Million | CN¥85.72 Million | CN¥66.81 Million | — |